Guangzhou Kingmed Diagnostics Group Co Ltd (603882) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.047x

Based on the latest financial reports, Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥327.19 Million ≈ $47.88 Million USD) by net assets (CN¥6.95 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Guangzhou Kingmed Diagnostics Group Co L for the company's overall valuation and market capitalisation.

Guangzhou Kingmed Diagnostics Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Kingmed Diagnostics Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Kingmed Diagnostics Group Co Ltd ranked by their cash flow conversion efficiency. Explore Guangzhou Kingmed Diagnostics Group Co L earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
IQM Quantum Computers Oyj American Depositary Shares NASDAQ:IQMX	-0.120x
Xianhe Co Ltd SHG:603733	0.080x
Guangdong Dowstone Technology Co Ltd SHE:300409	0.020x
Dgb Financial KO:139130	0.001x
Spectrum Brands Holdings Inc NYSE:SPB	0.044x
Dermapharm Holding SE XETRA:DMP	0.054x
StubHub Holdings, Inc. NYSE:STUB	0.002x
Leyard Optoelectronic SHE:300296	0.020x

Annual Cash Flow Conversion Efficiency for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2025. View today's stock price for Guangzhou Kingmed Diagnostics Group Co L for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥1.20 Billion ≈ $175.89 Million	0.175x	+44.54%
2024-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥906.35 Million ≈ $132.63 Million	0.121x	-15.80%
2023-12-31	CN¥8.55 Billion ≈ $1.25 Billion	CN¥1.23 Billion ≈ $180.11 Million	0.144x	-34.39%
2022-12-31	CN¥8.87 Billion ≈ $1.30 Billion	CN¥1.95 Billion ≈ $285.03 Million	0.219x	-31.44%
2021-12-31	CN¥6.52 Billion ≈ $954.46 Million	CN¥2.09 Billion ≈ $305.54 Million	0.320x	-18.53%
2020-12-31	CN¥3.88 Billion ≈ $567.27 Million	CN¥1.52 Billion ≈ $222.88 Million	0.393x	+38.16%
2019-12-31	CN¥2.33 Billion ≈ $340.32 Million	CN¥661.40 Million ≈ $96.78 Million	0.284x	+5.00%
2018-12-31	CN¥1.96 Billion ≈ $286.16 Million	CN¥529.62 Million ≈ $77.50 Million	0.271x	+66.60%
2017-12-31	CN¥1.74 Billion ≈ $255.22 Million	CN¥283.53 Million ≈ $41.49 Million	0.163x	-36.92%
2016-12-31	CN¥1.13 Billion ≈ $165.88 Million	CN¥292.14 Million ≈ $42.75 Million	0.258x	+12.24%
2015-12-31	CN¥959.84 Million ≈ $140.46 Million	CN¥220.39 Million ≈ $32.25 Million	0.230x	-60.20%
2014-12-31	CN¥391.72 Million ≈ $57.32 Million	CN¥225.97 Million ≈ $33.07 Million	0.577x	+97.31%
2013-12-31	CN¥258.41 Million ≈ $37.81 Million	CN¥75.55 Million ≈ $11.06 Million	0.292x	-32.66%
2012-12-31	CN¥203.69 Million ≈ $29.81 Million	CN¥88.44 Million ≈ $12.94 Million	0.434x	--

About Guangzhou Kingmed Diagnostics Group Co Ltd

SHG:603882 China Diagnostics & Research

Market Cap

$1.97 Billion

CN¥13.46 Billion CNY

Market Cap Rank

#6283 Global

#1243 in China

Share Price

CN¥29.06

Change (1 day)

+1.04%

52-Week Range

CN¥22.16 - CN¥37.03

All Time High

CN¥164.39